OPKO Health, Inc. 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-20 4:26 pm Purchase | 2023-04-12 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,558,602 14.300% | 701,459 (+24.55%) | Filing |
| 2023-02-03 4:10 pm Purchase | 2023-01-26 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,857,143 11.600% | 432,900 (+17.86%) | Filing |
| 2022-05-09 4:39 pm Purchase | 2022-04-29 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,424,242 21.200% | 2,424,242 (New Position) | Filing |